Literature DB >> 2597135

The use of benzyloxycarbonyl[125I]iodotyrosylalanyldiazomethane as a probe for active cysteine proteinases in human tissues.

R W Mason1, L T Bartholomew, B S Hardwick.   

Abstract

The ability of benzyloxycarbonyl-(125I)Tyr-Ala-CHN2 to label cysteine proteinases in a variety of human tissues was investigated. The inhibitor bound only to cathepsin B in tissues homogenized at pH 5.0. When liver was autolysed at pH 4.0 for up to 4 h, the inhibitor also bound to a protein of Mr 25,000. This was identified immunologically and chromatographically as cathepsin L. Both cathepsins B and L were found primarily in kidney, liver and spleen. In spleen, an additional protein of Mr 25,000 was also labelled. This protein could not be precipitated by antibodies to any of cathepsins B, H and L. This protein has tentatively been identified as human cathepsin S by its tissue distribution, chromatographic properties and molecular size. This work clearly shows that peptidyldiazomethanes are specific probes for cysteine proteinases, and that benzyloxycarbonyl-(125I)Tyr-Ala-CHN2 binds to three such enzymes in human tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597135      PMCID: PMC1133521          DOI: 10.1042/bj2630945

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.

Authors:  R W Mason; D Wilcox; P Wikstrom; E N Shaw
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

2.  A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells.

Authors:  S Buus; O Werdelin
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Active center differences between cathepsins L and B: the S1 binding region.

Authors:  H Kirschke; P Wikstrom; E Shaw
Journal:  FEBS Lett       Date:  1988-02-08       Impact factor: 4.124

4.  Co-operation between plasmin and elastase in elastin degradation by intact murine macrophages.

Authors:  H A Chapman; O L Stone
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

5.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.

Authors:  C Crawford; R W Mason; P Wikstrom; E Shaw
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

6.  Human liver cathepsin L.

Authors:  R W Mason; G D Green; A J Barrett
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

7.  Diazomethyl ketone substrate derivatives as active-site-directed inhibitors of thiol proteases. Papain.

Authors:  R Leary; D Larsen; H Watanabe; E Shaw
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

8.  Distribution of cathepsins B and H in rat tissues and peripheral blood cells.

Authors:  E Kominami; T Tsukahara; Y Bando; N Katunuma
Journal:  J Biochem       Date:  1985-07       Impact factor: 3.387

9.  Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15).

Authors:  H Kirschke; I Schmidt; B Wiederanders
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

10.  Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages.

Authors:  J J Reilly; R W Mason; P Chen; L J Joseph; V P Sukhatme; R Yee; H A Chapman
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

View more
  9 in total

Review 1.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

2.  Quantification of cathepsins B and L in cells.

Authors:  R Xing; A K Addington; R W Mason
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Inhibition of cysteine proteinases in lysosomes and whole cells.

Authors:  D Wilcox; R W Mason
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

4.  Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.

Authors:  R Xing; R W Mason
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 5.  Activity-based probes as a tool for functional proteomic analysis of proteases.

Authors:  Marko Fonović; Matthew Bogyo
Journal:  Expert Rev Proteomics       Date:  2008-10       Impact factor: 3.940

6.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.

Authors:  V Y Reddy; Q Y Zhang; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

7.  Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in Neuroblastoma.

Authors:  Mehrnoosh Soori; Guizhen Lu; Robert W Mason
Journal:  J Pharmacol Exp Ther       Date:  2015-12-10       Impact factor: 4.030

8.  Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.

Authors:  Karen Honey; Terry Nakagawa; Christoph Peters; Alexander Rudensky
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

Review 9.  Proteolysis and antigen presentation by MHC class II molecules.

Authors:  Paula Wolf Bryant; Ana-Maria Lennon-Duménil; Edda Fiebiger; Cécile Lagaudrière-Gesbert; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.